Facial Injectables | Asia Pacific | 2014 | Market Analysis
Valued at $588 million in 2013, the Asia Pacific market for facial injectables will be among the most rapidly growing global markets over the next ten years, expanding to reach a value of over $1.8 billion by 2022.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables (including botulinum toxins and dermal fillers) in the Asia Pacific region across a 10-year period.